Last year, the 20 largest orthopaedic device companies posted year-over-year revenue increases. That's a statement we haven't made for at least the last three years, and one we think indicates positive momentum. What fueled this growth? New product launches, acquisitions and international expansion were the most-cited contributors.
Over the last 100 years, orthopaedic surgery has migrated from therapies based on limb
removal to joint
replacement to tissue
repair, and we are beginning to see clinical solutions for tissue
regeneration. Scott P. Bruder, M.D., Ph.D. explains how these four Rs represent the history and future of clinical orthopaedics.
The $375MM transaction is slated to close within 2Q18. Paragon Medical, a Tier 1 manufacturer of orthopaedic implants, instruments, cases and trays, will join NN's Life Sciences division.
Nawana's experience includes 15+ years with Johnson & Johnson, primarily in the Medical Devices & Diagnostics segment and culminating in 2011 with his appointment as Worldwide President of DePuy Synthes Spine; during this time, he oversaw the integration of Synthes.
AK Medical, the largest orthopaedic implant manufacturer in China, was the first to commercialize 3D printing technology for joint and spine devices in the region. JRI, founded in 1970 by orthopaedic surgeon Dr. Ronald Furlong, was in 1985 the first company to produce a hydroxyapatite-coated hip.
The 2018 lineup boasts 50 speakers and 24 educational opportunities, including keynotes, workshops, rapid fires, panel discussions, the GE Additive Tech Center and the popular Surgeon Pod. Reap the benefits of multiple perspectives and wise counsel...
Register Today!
